Yuet-Kin Leung
Concepts (418)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Estrogen Receptor beta | 17 | 2019 | 56 | 3.770 |
Why?
| Prostatic Neoplasms | 15 | 2022 | 415 | 2.780 |
Why?
| Benzhydryl Compounds | 9 | 2021 | 75 | 2.180 |
Why?
| Phenols | 9 | 2021 | 120 | 2.120 |
Why?
| Endocrine Disruptors | 5 | 2023 | 27 | 1.760 |
Why?
| Estrogens | 7 | 2020 | 244 | 1.310 |
Why?
| DNA Methylation | 12 | 2019 | 574 | 1.270 |
Why?
| Epigenesis, Genetic | 9 | 2021 | 399 | 1.260 |
Why?
| Gene Expression Regulation, Neoplastic | 8 | 2017 | 866 | 1.130 |
Why?
| Estradiol | 9 | 2021 | 219 | 1.040 |
Why?
| Signal Transduction | 12 | 2021 | 1753 | 1.030 |
Why?
| Cell Movement | 4 | 2020 | 271 | 0.930 |
Why?
| Breast Neoplasms | 7 | 2016 | 1248 | 0.930 |
Why?
| Endocrine System | 1 | 2023 | 12 | 0.930 |
Why?
| Cell Line, Tumor | 20 | 2023 | 1550 | 0.910 |
Why?
| Receptors, Androgen | 2 | 2022 | 49 | 0.900 |
Why?
| Environmental Pollutants | 3 | 2018 | 101 | 0.840 |
Why?
| Occupational Exposure | 3 | 2021 | 129 | 0.830 |
Why?
| Cell Proliferation | 10 | 2022 | 1096 | 0.810 |
Why?
| Antineoplastic Agents | 5 | 2021 | 1300 | 0.800 |
Why?
| Protein Kinase Inhibitors | 5 | 2023 | 216 | 0.790 |
Why?
| Toxicity Tests | 1 | 2020 | 52 | 0.760 |
Why?
| Mammary Neoplasms, Experimental | 2 | 2017 | 135 | 0.680 |
Why?
| Chromosomes, Human, X | 1 | 2018 | 21 | 0.650 |
Why?
| Leukemia, Myeloid, Acute | 3 | 2023 | 191 | 0.590 |
Why?
| Environmental Exposure | 6 | 2018 | 205 | 0.570 |
Why?
| Humans | 55 | 2023 | 54284 | 0.550 |
Why?
| Protective Clothing | 1 | 2015 | 8 | 0.550 |
Why?
| Estrogen Antagonists | 1 | 2015 | 19 | 0.550 |
Why?
| Antineoplastic Agents, Hormonal | 2 | 2014 | 49 | 0.550 |
Why?
| Firefighters | 1 | 2015 | 7 | 0.550 |
Why?
| Response Elements | 2 | 2013 | 32 | 0.510 |
Why?
| Transcriptional Activation | 4 | 2013 | 134 | 0.510 |
Why?
| MicroRNAs | 3 | 2016 | 386 | 0.480 |
Why?
| Prostate | 6 | 2016 | 117 | 0.480 |
Why?
| Animals | 24 | 2022 | 14385 | 0.470 |
Why?
| Prenatal Exposure Delayed Effects | 4 | 2021 | 173 | 0.460 |
Why?
| Exons | 1 | 2013 | 105 | 0.450 |
Why?
| Promoter Regions, Genetic | 4 | 2019 | 520 | 0.450 |
Why?
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2013 | 158 | 0.430 |
Why?
| CpG Islands | 7 | 2019 | 104 | 0.420 |
Why?
| Apoptosis | 4 | 2022 | 1300 | 0.420 |
Why?
| Rats | 11 | 2021 | 3415 | 0.420 |
Why?
| Diet, High-Fat | 4 | 2021 | 216 | 0.420 |
Why?
| Female | 27 | 2023 | 28441 | 0.390 |
Why?
| Male | 30 | 2022 | 27334 | 0.390 |
Why?
| Proto-Oncogene Proteins c-ret | 2 | 2022 | 35 | 0.390 |
Why?
| Muscle Proteins | 1 | 2013 | 307 | 0.390 |
Why?
| Tumor Suppressor Protein p53 | 2 | 2019 | 250 | 0.380 |
Why?
| Receptors, Estrogen | 4 | 2019 | 131 | 0.370 |
Why?
| Pyrimidines | 2 | 2022 | 196 | 0.360 |
Why?
| Spermatogenesis | 2 | 2021 | 9 | 0.350 |
Why?
| Adenocarcinoma | 2 | 2011 | 428 | 0.350 |
Why?
| Air Pollutants, Occupational | 2 | 2020 | 18 | 0.330 |
Why?
| HEK293 Cells | 5 | 2021 | 245 | 0.330 |
Why?
| Maternal Exposure | 2 | 2021 | 87 | 0.330 |
Why?
| RNA, Messenger | 5 | 2022 | 1202 | 0.330 |
Why?
| Orphan Nuclear Receptors | 2 | 2019 | 15 | 0.330 |
Why?
| fms-Like Tyrosine Kinase 3 | 3 | 2023 | 16 | 0.320 |
Why?
| Dose-Response Relationship, Drug | 6 | 2021 | 1476 | 0.320 |
Why?
| Transcription, Genetic | 4 | 2013 | 418 | 0.310 |
Why?
| Epigenomics | 2 | 2019 | 67 | 0.310 |
Why?
| Protein Isoforms | 4 | 2013 | 124 | 0.300 |
Why?
| Mutation | 5 | 2023 | 1501 | 0.280 |
Why?
| Gene Expression Profiling | 5 | 2015 | 1138 | 0.270 |
Why?
| Phosphorylation | 5 | 2021 | 614 | 0.270 |
Why?
| Pregnancy | 8 | 2023 | 2620 | 0.260 |
Why?
| Cytochrome P-450 CYP1A1 | 1 | 2005 | 46 | 0.260 |
Why?
| Androgens | 2 | 2022 | 68 | 0.260 |
Why?
| Lung Neoplasms | 3 | 2022 | 642 | 0.260 |
Why?
| Protein Processing, Post-Translational | 3 | 2012 | 183 | 0.250 |
Why?
| Chironomidae | 1 | 2004 | 1 | 0.250 |
Why?
| Ferrochelatase | 1 | 2004 | 1 | 0.250 |
Why?
| Mass Spectrometry | 1 | 2006 | 313 | 0.250 |
Why?
| Veterans | 2 | 2021 | 629 | 0.240 |
Why?
| Butter | 2 | 2021 | 6 | 0.240 |
Why?
| Copper | 1 | 2004 | 48 | 0.240 |
Why?
| Structure-Activity Relationship | 5 | 2022 | 423 | 0.240 |
Why?
| NF-kappa B | 1 | 2006 | 335 | 0.240 |
Why?
| Glycyrrhiza | 1 | 2003 | 4 | 0.240 |
Why?
| Proteome | 1 | 2006 | 178 | 0.240 |
Why?
| Pyridines | 2 | 2023 | 137 | 0.240 |
Why?
| Nanoparticles | 2 | 2016 | 173 | 0.240 |
Why?
| Drug Discovery | 2 | 2021 | 90 | 0.240 |
Why?
| Proto-Oncogene Proteins c-fos | 1 | 2003 | 65 | 0.240 |
Why?
| Proteins | 2 | 2006 | 376 | 0.230 |
Why?
| Binding Sites | 2 | 2022 | 440 | 0.230 |
Why?
| Hormones | 1 | 2023 | 59 | 0.230 |
Why?
| Tumor Suppressor Proteins | 2 | 2020 | 141 | 0.220 |
Why?
| Antineoplastic Agents, Phytogenic | 3 | 2016 | 87 | 0.210 |
Why?
| Methylcholanthrene | 1 | 2002 | 10 | 0.210 |
Why?
| Sp3 Transcription Factor | 1 | 2022 | 4 | 0.210 |
Why?
| Neoplasm Invasiveness | 2 | 2014 | 295 | 0.210 |
Why?
| RNA Polymerase II | 1 | 2022 | 17 | 0.210 |
Why?
| Sp1 Transcription Factor | 1 | 2022 | 18 | 0.210 |
Why?
| Infertility, Male | 1 | 2021 | 14 | 0.210 |
Why?
| Aminoquinolines | 1 | 2021 | 11 | 0.200 |
Why?
| Phthalazines | 1 | 2021 | 19 | 0.200 |
Why?
| Thiophenes | 1 | 2021 | 37 | 0.200 |
Why?
| Disease Susceptibility | 2 | 2012 | 95 | 0.200 |
Why?
| Plant Extracts | 1 | 2003 | 193 | 0.200 |
Why?
| Forkhead Transcription Factors | 2 | 2012 | 118 | 0.200 |
Why?
| Computational Biology | 3 | 2019 | 231 | 0.200 |
Why?
| Risk | 3 | 2017 | 343 | 0.190 |
Why?
| Dietary Fats | 1 | 2021 | 142 | 0.190 |
Why?
| Intracellular Signaling Peptides and Proteins | 1 | 2021 | 151 | 0.190 |
Why?
| Ovarian Neoplasms | 1 | 2005 | 472 | 0.190 |
Why?
| Transforming Growth Factor beta | 1 | 2021 | 158 | 0.190 |
Why?
| DNA Modification Methylases | 1 | 2020 | 32 | 0.190 |
Why?
| Isocitrate Dehydrogenase | 1 | 2020 | 21 | 0.190 |
Why?
| Glucuronosyltransferase | 1 | 2002 | 157 | 0.190 |
Why?
| Sleep Initiation and Maintenance Disorders | 1 | 2020 | 43 | 0.190 |
Why?
| Estrogen Receptor alpha | 3 | 2019 | 95 | 0.190 |
Why?
| Pyruvate Kinase | 1 | 2020 | 8 | 0.190 |
Why?
| DNA Repair Enzymes | 1 | 2020 | 50 | 0.180 |
Why?
| Pyrroles | 1 | 2020 | 78 | 0.180 |
Why?
| Hair | 2 | 2018 | 53 | 0.180 |
Why?
| Sequence Analysis, RNA | 1 | 2020 | 107 | 0.180 |
Why?
| Pharyngeal Neoplasms | 1 | 2019 | 1 | 0.180 |
Why?
| Molecular Sequence Data | 4 | 2006 | 980 | 0.180 |
Why?
| Random Allocation | 2 | 2017 | 312 | 0.180 |
Why?
| Drug Design | 1 | 2020 | 133 | 0.180 |
Why?
| Glioma | 1 | 2020 | 78 | 0.180 |
Why?
| Mouth Neoplasms | 1 | 2019 | 25 | 0.180 |
Why?
| Up-Regulation | 3 | 2019 | 508 | 0.180 |
Why?
| Endometrial Neoplasms | 1 | 2020 | 144 | 0.180 |
Why?
| Collagen Type III | 1 | 2019 | 10 | 0.170 |
Why?
| Carcinoma, Hepatocellular | 1 | 2002 | 203 | 0.170 |
Why?
| Subcellular Fractions | 2 | 2012 | 43 | 0.170 |
Why?
| Anxiety | 1 | 2020 | 279 | 0.170 |
Why?
| Liver Failure, Acute | 1 | 2019 | 64 | 0.170 |
Why?
| Tissue Array Analysis | 3 | 2016 | 50 | 0.170 |
Why?
| Amino Acid Sequence | 3 | 2006 | 767 | 0.160 |
Why?
| Military Personnel | 1 | 2020 | 174 | 0.160 |
Why?
| Stress, Psychological | 1 | 2020 | 270 | 0.160 |
Why?
| Denmark | 1 | 2018 | 42 | 0.160 |
Why?
| Methylmercury Compounds | 1 | 2018 | 13 | 0.160 |
Why?
| Mice | 5 | 2022 | 6413 | 0.160 |
Why?
| Collagen Type I | 1 | 2019 | 97 | 0.160 |
Why?
| Polychlorinated Biphenyls | 1 | 2018 | 26 | 0.160 |
Why?
| Fetal Blood | 1 | 2018 | 67 | 0.160 |
Why?
| Pregnancy in Diabetics | 1 | 2018 | 25 | 0.160 |
Why?
| Histone Demethylases | 1 | 2017 | 15 | 0.160 |
Why?
| Receptors, Aryl Hydrocarbon | 1 | 2017 | 29 | 0.160 |
Why?
| Urethane | 1 | 2017 | 8 | 0.160 |
Why?
| Depressive Disorder | 1 | 2020 | 368 | 0.150 |
Why?
| Water Pollutants, Chemical | 1 | 2018 | 55 | 0.150 |
Why?
| Infant, Newborn | 3 | 2023 | 2907 | 0.150 |
Why?
| Pneumonia, Viral | 1 | 2020 | 184 | 0.150 |
Why?
| Neoplasms | 2 | 2005 | 1316 | 0.150 |
Why?
| Coronavirus Infections | 1 | 2020 | 192 | 0.150 |
Why?
| Mammary Glands, Animal | 1 | 2017 | 69 | 0.150 |
Why?
| Cells, Cultured | 4 | 2019 | 1737 | 0.150 |
Why?
| Cholesterol | 1 | 2017 | 155 | 0.150 |
Why?
| Protein Binding | 2 | 2011 | 736 | 0.150 |
Why?
| 5-Methylcytosine | 1 | 2016 | 18 | 0.140 |
Why?
| Research Design | 1 | 2019 | 374 | 0.140 |
Why?
| Brain Neoplasms | 1 | 2020 | 284 | 0.140 |
Why?
| Fibroblasts | 1 | 2019 | 386 | 0.140 |
Why?
| Gene Expression | 2 | 2018 | 664 | 0.140 |
Why?
| Placenta | 1 | 2018 | 135 | 0.140 |
Why?
| Sex Characteristics | 1 | 2018 | 214 | 0.140 |
Why?
| Immunohistochemistry | 4 | 2016 | 1089 | 0.140 |
Why?
| Rats, Sprague-Dawley | 5 | 2021 | 1663 | 0.140 |
Why?
| Environmental Health | 1 | 2016 | 12 | 0.140 |
Why?
| Sexual Maturation | 1 | 2015 | 13 | 0.140 |
Why?
| Reproduction | 1 | 2016 | 56 | 0.140 |
Why?
| Heart Diseases | 1 | 2019 | 237 | 0.140 |
Why?
| Embryo Implantation | 1 | 2015 | 7 | 0.140 |
Why?
| Paclitaxel | 1 | 2016 | 103 | 0.140 |
Why?
| Myocardium | 1 | 2019 | 441 | 0.140 |
Why?
| Adult | 8 | 2020 | 14207 | 0.140 |
Why?
| Embryonic Development | 1 | 2015 | 17 | 0.140 |
Why?
| Membrane Proteins | 2 | 2010 | 389 | 0.140 |
Why?
| Receptors, G-Protein-Coupled | 1 | 2016 | 55 | 0.130 |
Why?
| Carcinoma, Squamous Cell | 1 | 2019 | 384 | 0.130 |
Why?
| Myeloid Cells | 1 | 2015 | 37 | 0.130 |
Why?
| Interferons | 1 | 2015 | 44 | 0.130 |
Why?
| RNA, Untranslated | 1 | 2015 | 17 | 0.130 |
Why?
| Prostatectomy | 1 | 2016 | 87 | 0.130 |
Why?
| Histone Code | 1 | 2015 | 32 | 0.130 |
Why?
| Image Interpretation, Computer-Assisted | 1 | 2016 | 119 | 0.130 |
Why?
| Polyglycolic Acid | 1 | 2015 | 7 | 0.130 |
Why?
| Histidine | 1 | 2015 | 17 | 0.130 |
Why?
| Pandemics | 1 | 2020 | 579 | 0.130 |
Why?
| Chemistry, Pharmaceutical | 1 | 2015 | 39 | 0.130 |
Why?
| Particle Size | 1 | 2015 | 88 | 0.130 |
Why?
| Tumor Cells, Cultured | 3 | 2022 | 477 | 0.130 |
Why?
| Inflammasomes | 1 | 2015 | 60 | 0.130 |
Why?
| Receptor, erbB-2 | 1 | 2015 | 79 | 0.130 |
Why?
| Image Processing, Computer-Assisted | 1 | 2016 | 256 | 0.130 |
Why?
| Lysosomes | 1 | 2015 | 91 | 0.130 |
Why?
| Drug Carriers | 1 | 2015 | 81 | 0.130 |
Why?
| HMGA Proteins | 1 | 2014 | 2 | 0.130 |
Why?
| Polycomb Repressive Complex 2 | 1 | 2014 | 50 | 0.130 |
Why?
| Lactic Acid | 1 | 2015 | 90 | 0.130 |
Why?
| Polyethylene Glycols | 1 | 2015 | 106 | 0.120 |
Why?
| Caspase 7 | 1 | 2013 | 11 | 0.120 |
Why?
| Base Sequence | 3 | 2005 | 719 | 0.120 |
Why?
| Isoenzymes | 2 | 2005 | 177 | 0.120 |
Why?
| Kaplan-Meier Estimate | 2 | 2017 | 514 | 0.120 |
Why?
| MCF-7 Cells | 1 | 2013 | 79 | 0.120 |
Why?
| 5' Untranslated Regions | 1 | 2013 | 33 | 0.120 |
Why?
| Histone Acetyltransferases | 1 | 2013 | 22 | 0.120 |
Why?
| Open Reading Frames | 1 | 2013 | 55 | 0.120 |
Why?
| Liver Neoplasms | 1 | 2017 | 352 | 0.110 |
Why?
| Histones | 2 | 2015 | 335 | 0.110 |
Why?
| Repressor Proteins | 1 | 2014 | 165 | 0.110 |
Why?
| Drug Delivery Systems | 1 | 2015 | 151 | 0.110 |
Why?
| Estrogens, Non-Steroidal | 2 | 2015 | 14 | 0.110 |
Why?
| Vehicle Emissions | 1 | 2012 | 17 | 0.110 |
Why?
| Transcriptome | 1 | 2015 | 346 | 0.110 |
Why?
| DNA | 1 | 2016 | 581 | 0.110 |
Why?
| Genetic Predisposition to Disease | 1 | 2015 | 570 | 0.110 |
Why?
| Air Pollutants | 1 | 2012 | 70 | 0.110 |
Why?
| Models, Biological | 2 | 2017 | 823 | 0.110 |
Why?
| RNA Splicing | 1 | 2012 | 38 | 0.100 |
Why?
| Doxorubicin | 1 | 2013 | 259 | 0.100 |
Why?
| Aged | 6 | 2020 | 10054 | 0.100 |
Why?
| Extracellular Signal-Regulated MAP Kinases | 1 | 2012 | 101 | 0.100 |
Why?
| p38 Mitogen-Activated Protein Kinases | 1 | 2012 | 99 | 0.100 |
Why?
| MAP Kinase Signaling System | 1 | 2012 | 133 | 0.100 |
Why?
| Antibodies | 1 | 2012 | 178 | 0.100 |
Why?
| Health Knowledge, Attitudes, Practice | 1 | 2016 | 543 | 0.100 |
Why?
| Diet | 1 | 2015 | 598 | 0.100 |
Why?
| Cisplatin | 1 | 2013 | 352 | 0.100 |
Why?
| Kruppel-Like Transcription Factors | 1 | 2011 | 40 | 0.100 |
Why?
| Protein Biosynthesis | 1 | 2013 | 273 | 0.100 |
Why?
| Racemases and Epimerases | 1 | 2011 | 15 | 0.100 |
Why?
| Risk Factors | 3 | 2020 | 3935 | 0.100 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2015 | 673 | 0.100 |
Why?
| Cell Nucleus | 2 | 2016 | 203 | 0.100 |
Why?
| Cell Transformation, Neoplastic | 2 | 2017 | 200 | 0.100 |
Why?
| Molecular Structure | 2 | 2021 | 319 | 0.090 |
Why?
| Cell Cycle | 1 | 2012 | 275 | 0.090 |
Why?
| Models, Genetic | 1 | 2011 | 209 | 0.090 |
Why?
| Introns | 1 | 2010 | 49 | 0.090 |
Why?
| Middle Aged | 6 | 2020 | 13088 | 0.090 |
Why?
| Testosterone | 2 | 2016 | 119 | 0.090 |
Why?
| Manganese Poisoning | 1 | 2009 | 4 | 0.090 |
Why?
| Gene Silencing | 1 | 2010 | 129 | 0.090 |
Why?
| Carcinogens | 2 | 2015 | 231 | 0.090 |
Why?
| Gene Expression Regulation | 3 | 2015 | 1062 | 0.090 |
Why?
| Disease-Free Survival | 1 | 2010 | 485 | 0.090 |
Why?
| Proportional Hazards Models | 1 | 2010 | 431 | 0.080 |
Why?
| Asthma | 1 | 2012 | 293 | 0.080 |
Why?
| Oligonucleotide Array Sequence Analysis | 3 | 2007 | 474 | 0.080 |
Why?
| Methylation | 2 | 2020 | 130 | 0.080 |
Why?
| Community-Based Participatory Research | 1 | 2009 | 209 | 0.080 |
Why?
| Enzyme Activation | 2 | 2006 | 329 | 0.080 |
Why?
| Apigenin | 1 | 2006 | 5 | 0.070 |
Why?
| Estrogen Receptor Modulators | 1 | 2006 | 6 | 0.070 |
Why?
| Sequence Analysis, DNA | 2 | 2019 | 273 | 0.070 |
Why?
| Presenilin-2 | 1 | 2006 | 3 | 0.070 |
Why?
| Yeasts | 1 | 2006 | 10 | 0.070 |
Why?
| Sequence Analysis, Protein | 1 | 2006 | 21 | 0.070 |
Why?
| Dimerization | 1 | 2006 | 59 | 0.070 |
Why?
| Growth Differentiation Factor 1 | 1 | 2006 | 2 | 0.070 |
Why?
| Interleukin-12 | 1 | 2006 | 37 | 0.070 |
Why?
| Receptor Protein-Tyrosine Kinases | 1 | 2006 | 52 | 0.070 |
Why?
| Interleukin-8 | 1 | 2006 | 97 | 0.070 |
Why?
| Sex Factors | 2 | 2019 | 767 | 0.070 |
Why?
| Cohort Studies | 1 | 2010 | 1543 | 0.070 |
Why?
| Intercellular Signaling Peptides and Proteins | 1 | 2006 | 122 | 0.070 |
Why?
| Epithelium | 1 | 2005 | 68 | 0.070 |
Why?
| Molecular Conformation | 1 | 2005 | 73 | 0.060 |
Why?
| Benzo(a)pyrene | 1 | 2005 | 38 | 0.060 |
Why?
| Models, Molecular | 1 | 2006 | 423 | 0.060 |
Why?
| Genes, p53 | 1 | 2005 | 60 | 0.060 |
Why?
| Alternative Splicing | 1 | 2005 | 64 | 0.060 |
Why?
| Ovary | 1 | 2005 | 105 | 0.060 |
Why?
| Genes, Tumor Suppressor | 1 | 2005 | 85 | 0.060 |
Why?
| Cations, Divalent | 1 | 2004 | 8 | 0.060 |
Why?
| Iron-Sulfur Proteins | 1 | 2004 | 9 | 0.060 |
Why?
| Disease Models, Animal | 2 | 2021 | 1639 | 0.060 |
Why?
| Transfection | 1 | 2005 | 399 | 0.060 |
Why?
| Metals | 1 | 2004 | 44 | 0.060 |
Why?
| Cloning, Molecular | 1 | 2004 | 198 | 0.060 |
Why?
| Sequence Alignment | 1 | 2004 | 146 | 0.060 |
Why?
| Receptors, Urokinase Plasminogen Activator | 1 | 2003 | 3 | 0.060 |
Why?
| Survival Analysis | 2 | 2016 | 735 | 0.060 |
Why?
| Plasminogen Activator Inhibitor 1 | 1 | 2003 | 9 | 0.060 |
Why?
| Glutathione S-Transferase pi | 1 | 2003 | 20 | 0.060 |
Why?
| NAD(P)H Dehydrogenase (Quinone) | 1 | 2003 | 24 | 0.060 |
Why?
| Deoxyguanosine | 1 | 2003 | 32 | 0.060 |
Why?
| Blotting, Northern | 1 | 2003 | 108 | 0.060 |
Why?
| Clone Cells | 1 | 2003 | 89 | 0.060 |
Why?
| Molecular Docking Simulation | 1 | 2023 | 83 | 0.060 |
Why?
| Transcription Factor AP-1 | 1 | 2003 | 64 | 0.060 |
Why?
| Cell Survival | 2 | 2021 | 657 | 0.060 |
Why?
| Pilot Projects | 2 | 2020 | 808 | 0.060 |
Why?
| Receptors, Cell Surface | 1 | 2003 | 130 | 0.060 |
Why?
| Glutathione Transferase | 1 | 2003 | 178 | 0.060 |
Why?
| Metabolome | 1 | 2023 | 109 | 0.050 |
Why?
| Kinetics | 1 | 2004 | 692 | 0.050 |
Why?
| Metabolomics | 1 | 2023 | 149 | 0.050 |
Why?
| Young Adult | 3 | 2020 | 4318 | 0.050 |
Why?
| Mice, Inbred C57BL | 2 | 2019 | 1999 | 0.050 |
Why?
| Herbal Medicine | 1 | 2002 | 3 | 0.050 |
Why?
| Dactinomycin | 1 | 2002 | 23 | 0.050 |
Why?
| Nucleic Acid Synthesis Inhibitors | 1 | 2002 | 17 | 0.050 |
Why?
| RNA Stability | 1 | 2002 | 28 | 0.050 |
Why?
| Inheritance Patterns | 1 | 2021 | 27 | 0.050 |
Why?
| Smad Proteins | 1 | 2021 | 13 | 0.050 |
Why?
| Receptors, Transforming Growth Factor beta | 1 | 2021 | 26 | 0.050 |
Why?
| Incineration | 1 | 2021 | 6 | 0.050 |
Why?
| Amino Acids | 1 | 2023 | 369 | 0.050 |
Why?
| Testis | 1 | 2021 | 65 | 0.050 |
Why?
| Maternal Nutritional Physiological Phenomena | 1 | 2021 | 51 | 0.050 |
Why?
| Drug Screening Assays, Antitumor | 1 | 2021 | 142 | 0.050 |
Why?
| Prognosis | 2 | 2017 | 2118 | 0.050 |
Why?
| Phytoestrogens | 2 | 2014 | 20 | 0.050 |
Why?
| Staining and Labeling | 2 | 2016 | 106 | 0.050 |
Why?
| Loneliness | 1 | 2020 | 13 | 0.050 |
Why?
| Mitochondria | 1 | 2005 | 489 | 0.050 |
Why?
| Hypesthesia | 1 | 2020 | 18 | 0.050 |
Why?
| Small Molecule Libraries | 1 | 2021 | 72 | 0.050 |
Why?
| Drug Evaluation, Preclinical | 1 | 2021 | 158 | 0.050 |
Why?
| Chemistry Techniques, Synthetic | 1 | 2020 | 20 | 0.050 |
Why?
| Alcohol Oxidoreductases | 1 | 2020 | 14 | 0.050 |
Why?
| Lymphangioleiomyomatosis | 1 | 2020 | 5 | 0.050 |
Why?
| Memory Disorders | 1 | 2020 | 62 | 0.050 |
Why?
| Wound Healing | 1 | 2022 | 228 | 0.050 |
Why?
| Fear | 1 | 2020 | 87 | 0.050 |
Why?
| Hep G2 Cells | 1 | 2019 | 46 | 0.040 |
Why?
| Adaptation, Psychological | 1 | 2020 | 244 | 0.040 |
Why?
| Acetylcysteine | 1 | 2019 | 118 | 0.040 |
Why?
| Rats, Wistar | 1 | 2019 | 237 | 0.040 |
Why?
| Cross-Sectional Studies | 1 | 2023 | 1693 | 0.040 |
Why?
| Linear Models | 1 | 2019 | 309 | 0.040 |
Why?
| Fibrosis | 1 | 2019 | 208 | 0.040 |
Why?
| Oxidative Stress | 1 | 2003 | 958 | 0.040 |
Why?
| Diet, Atherogenic | 1 | 2017 | 9 | 0.040 |
Why?
| Biopsy | 1 | 2020 | 692 | 0.040 |
Why?
| Injections, Intraperitoneal | 1 | 2017 | 59 | 0.040 |
Why?
| Bronchoalveolar Lavage Fluid | 1 | 2017 | 35 | 0.040 |
Why?
| Aging | 1 | 2003 | 784 | 0.040 |
Why?
| Calcium Phosphates | 1 | 2016 | 8 | 0.040 |
Why?
| Gene Regulatory Networks | 1 | 2017 | 124 | 0.040 |
Why?
| Polymers | 1 | 2016 | 44 | 0.040 |
Why?
| Lung | 1 | 2020 | 507 | 0.040 |
Why?
| Genetic Loci | 1 | 2016 | 58 | 0.040 |
Why?
| Mice, Knockout | 1 | 2019 | 926 | 0.040 |
Why?
| Ethinyl Estradiol | 1 | 2015 | 8 | 0.030 |
Why?
| Exercise | 1 | 2020 | 552 | 0.030 |
Why?
| High-Throughput Nucleotide Sequencing | 1 | 2017 | 206 | 0.030 |
Why?
| 9,10-Dimethyl-1,2-benzanthracene | 1 | 2015 | 54 | 0.030 |
Why?
| Age Factors | 2 | 2014 | 1198 | 0.030 |
Why?
| Acetaminophen | 1 | 2019 | 349 | 0.030 |
Why?
| Environment | 1 | 2016 | 103 | 0.030 |
Why?
| Models, Theoretical | 1 | 2016 | 184 | 0.030 |
Why?
| Sp Transcription Factors | 1 | 2014 | 6 | 0.030 |
Why?
| Pentacyclic Triterpenes | 1 | 2014 | 8 | 0.030 |
Why?
| Triterpenes | 1 | 2014 | 13 | 0.030 |
Why?
| Neoplasm Transplantation | 1 | 2014 | 94 | 0.030 |
Why?
| Cluster Analysis | 1 | 2015 | 249 | 0.030 |
Why?
| Transplantation, Heterologous | 1 | 2014 | 77 | 0.030 |
Why?
| Lupus Erythematosus, Systemic | 1 | 2015 | 76 | 0.030 |
Why?
| Lysine | 1 | 2015 | 102 | 0.030 |
Why?
| Schools | 1 | 2016 | 176 | 0.030 |
Why?
| Gestational Age | 1 | 2016 | 435 | 0.030 |
Why?
| Immunity, Innate | 1 | 2015 | 114 | 0.030 |
Why?
| Case-Control Studies | 1 | 2018 | 1228 | 0.030 |
Why?
| Mice, Nude | 1 | 2014 | 283 | 0.030 |
Why?
| Real-Time Polymerase Chain Reaction | 1 | 2014 | 206 | 0.030 |
Why?
| Stem Cells | 1 | 2015 | 193 | 0.030 |
Why?
| Genome | 1 | 2014 | 74 | 0.030 |
Why?
| Epithelial Cells | 1 | 2015 | 255 | 0.030 |
Why?
| Acetylation | 1 | 2013 | 99 | 0.030 |
Why?
| Blotting, Western | 1 | 2014 | 683 | 0.030 |
Why?
| Life Style | 1 | 2014 | 156 | 0.030 |
Why?
| Saliva | 1 | 2012 | 63 | 0.030 |
Why?
| Infant | 2 | 2012 | 3817 | 0.030 |
Why?
| Reproducibility of Results | 1 | 2016 | 1304 | 0.030 |
Why?
| Child, Preschool | 2 | 2012 | 4147 | 0.030 |
Why?
| Cell Line | 1 | 2015 | 1153 | 0.030 |
Why?
| Diabetes Mellitus, Type 2 | 1 | 2018 | 486 | 0.030 |
Why?
| Neoplasm Recurrence, Local | 1 | 2016 | 644 | 0.030 |
Why?
| Nerve Tissue Proteins | 1 | 2013 | 199 | 0.030 |
Why?
| Carrier Proteins | 1 | 2013 | 359 | 0.020 |
Why?
| Adolescent | 2 | 2016 | 6897 | 0.020 |
Why?
| In Situ Hybridization | 1 | 2010 | 82 | 0.020 |
Why?
| Electrophoretic Mobility Shift Assay | 1 | 2010 | 74 | 0.020 |
Why?
| Hemochromatosis | 1 | 2009 | 5 | 0.020 |
Why?
| Antigens, Surface | 1 | 2009 | 55 | 0.020 |
Why?
| Manganese | 1 | 2009 | 24 | 0.020 |
Why?
| Ohio | 1 | 2009 | 67 | 0.020 |
Why?
| Statistics as Topic | 1 | 2009 | 103 | 0.020 |
Why?
| Obesity | 1 | 2018 | 1202 | 0.020 |
Why?
| Child | 2 | 2012 | 7341 | 0.020 |
Why?
| Dihydrotestosterone | 1 | 2007 | 14 | 0.020 |
Why?
| Anticarcinogenic Agents | 1 | 2006 | 35 | 0.020 |
Why?
| Polymorphism, Single Nucleotide | 1 | 2009 | 552 | 0.020 |
Why?
| Caspase 3 | 1 | 2006 | 135 | 0.020 |
Why?
| Down-Regulation | 1 | 2007 | 388 | 0.020 |
Why?
| RNA, Small Interfering | 1 | 2006 | 252 | 0.020 |
Why?
| TATA Box | 1 | 2004 | 9 | 0.020 |
Why?
| Dinucleoside Phosphates | 1 | 2004 | 6 | 0.020 |
Why?
| DNA Primers | 1 | 2004 | 225 | 0.020 |
Why?
| Rats, Inbred Strains | 1 | 2003 | 172 | 0.010 |
Why?
| Orchiectomy | 1 | 2003 | 38 | 0.010 |
Why?
| Oxidoreductases | 1 | 2003 | 62 | 0.010 |
Why?
| Precancerous Conditions | 1 | 2004 | 93 | 0.010 |
Why?
| Peptide Elongation Factor 1 | 1 | 2003 | 2 | 0.010 |
Why?
| Clusterin | 1 | 2003 | 6 | 0.010 |
Why?
| Amino Acyl-tRNA Synthetases | 1 | 2003 | 6 | 0.010 |
Why?
| Retrospective Studies | 1 | 2016 | 6432 | 0.010 |
Why?
| Neoplasm Metastasis | 1 | 2004 | 252 | 0.010 |
Why?
| Aldehydes | 1 | 2003 | 97 | 0.010 |
Why?
| Regeneration | 1 | 2003 | 72 | 0.010 |
Why?
| Cytoskeleton | 1 | 2003 | 50 | 0.010 |
Why?
| Postoperative Period | 1 | 2003 | 189 | 0.010 |
Why?
| Molecular Chaperones | 1 | 2003 | 64 | 0.010 |
Why?
| Alkaline Phosphatase | 1 | 2003 | 99 | 0.010 |
Why?
| Glycoproteins | 1 | 2003 | 132 | 0.010 |
Why?
| Membrane Glycoproteins | 1 | 2003 | 269 | 0.010 |
Why?
| Aged, 80 and over | 1 | 2009 | 3431 | 0.010 |
Why?
| Neoplasm Staging | 1 | 2004 | 806 | 0.010 |
Why?
|
|
Leung's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|